Europe considers 'dose-sparing' to increase monkeypox vaccine, WHO seeks trials - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABCNews
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 51%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Health officials in Europe are discussing whether to follow a move by the United States to stretch out scarce monkeypox vaccine supplies, with the World Health Organisation calling for more data.

A nurse holds a monkeypox vaccination at the Northwell Health Immediate Care Center at Fire Island-Cherry Grove, in New York, U.S., July 15, 2022.A nurse holds a monkeypox vaccination at the Northwell Health Immediate Care Center at Fire Island-Cherry Grove, in New York, U.S., July 15, 2022.

Supplies of the key Bavarian Nordic shot, the only vaccine authorised to prevent monkeypox and a key part of the global public health response, are scarce, according to WHO and other government health agencies. According to the US Food and Drug Administration, data collected in a 2015 clinical study demonstrated that dose-sparing could work without sacrificing the safety and efficacy of the vaccine.

It is unclear whether either approach will result in adequate protection against monkeypox, which is usually a mild to moderate infection that leads to flu-like symptoms and characteristic pus-filled skin lesions.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 37. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し